fda rules on compounded semaglutide is not the same as FDA-approved. The has documented dosing errors and hospitalizations linked to these products. Dr. Jen Ashton breaks down the risks. Always consult your physician before The FDA's Decision to Ban

Initially developed to treat Type 2 Diabetes, these medications have since been studied for its role in supporting weight loss as well

Clinical studies and meta-analyses have identified an increased risk of gallbladder disease with GLP-1 receptor agonist use, particularly with weight loss medications

Patients typically take methotrexate once weekly (orally or by subcutaneous injection), alongside folic acid supplementation to minimise side effects

Ozempic is injected once every week under the skin of the abdomen, thigh, or upper arm

The goal is always: Sustainable results Healthy relationship with food Confidence in maintaining weight This is where understanding Tapering vs maintenance dosing for weight loss in Chicago becomes critical

For weight management, medications like semaglutide 2.4mg (Wegovy) are typically initiated by specialist weight management services with specific BMI thresholds and are more restricted than diabetes formulations